Enzymes and
acute
myocardial
infarction
Elizabeta Eftimova – First Group
Enzymes in Acute Myocardial
Infraction

Acute myocardial infarction (AMI), commonly known as a heart
attack, results from sudden blockage of blood flow to a portion of
the heart muscle, leading to tissue damage and cell death.

Role of Enzymes: Enzymes released from damaged heart tissue,
such as troponin, creatine kinase (CK), and lactate dehydrogenase
(LDH), serve as sensitive markers for diagnosing AMI and assessing
its severity. Elevated levels of cardiac enzymes, particularly
troponin, are highly specific indicators of myocardial injury and are
considered the gold standard biomarker for diagnosing AMI.
Measurement of cardiac enzymes plays a crucial role in the
diagnosis, risk stratification, and management of patients with AMI,
aiding in timely intervention and improving patient
outcomes.Understanding the role of enzymes in AMI diagnosis is
essential for effective clinical decision-making and optimizing
patient care in acute coronary syndromes.
Acute Myocardial Infraction

Acute myocardial infarction (AMI), commonly
known as a heart attack, occurs when there is a
sudden blockage of blood flow to a portion of
the heart muscle, leading to tissue damage
and cell death. This obstruction typically results
from the rupture of an atherosclerotic plaque in
a coronary artery, causing thrombus formation
and subsequent ischemia. Clinically, AMI
presents with symptoms such as chest pain or
discomfort, shortness of breath, nausea, and
sweating. Prompt diagnosis and treatment are
critical to minimize myocardial damage and
improve patient outcomes. Complications of
AMI include arrhythmias, heart failure, and
cardiogenic shock, highlighting the importance
of timely intervention and ongoing
management.
Cardiac enzymes in Acute
Myocardial Infraction

Cardiac enzymes, including troponin, creatine kinase (CK), and
lactate dehydrogenase (LDH), are released into the bloodstream
following myocardial injury during acute myocardial infarction
(AMI). Elevated levels of these enzymes serve as sensitive markers
for diagnosing AMI and assessing its severity. Measurement of
cardiac enzymes plays a crucial role in guiding clinical
management and treatment decisions for patients with AMI.
Troponin and Creatine Kinase
 Troponin is a regulatory
protein found in
cardiac muscle, with its
release into the
bloodstream indicating
myocardial injury.
Elevated troponin
levels are highly
specific for myocardial
damage and are used
as the gold standard
biomarker for
diagnosing AMI.
 CK is an enzyme found
in cardiac muscle, with
its release into the
bloodstream indicating
myocardial injury.CKMB is the cardiacspecific isoenzyme of
CK, and its elevation in
serum is indicative of
myocardial damage.
Lactate Dehydrogenase
 LDH is an enzyme found in various tissues,
including the heart, and its elevation in serum
indicates tissue damage. LDH is less specific
for myocardial injury compared to troponin
and CK but can be used in conjunction with
other markers.
Clinical implications and
conclusion
 Clinical Implications: Measurement of
cardiac enzymes, particularly troponin,
CK-MB, and LDH, plays a crucial role in
the diagnosis, risk stratification, and
management of patients with AMI.
 Conclusion: Understanding the role of
enzymes as diagnostic markers for AMI is
essential for timely intervention and
improving outcomes in patients with
acute coronary syndromes.